HLA alleles may serve as a tool to discriminate atypical type 2 diabetic patients

Table 3 Clinical characteristics expressed by media and standard deviation

	Sample A n = 93	Sample B n = 106	P value
Age (yr)	62.01 ± 11.65	66.02 ± 9.55	0.060
Age onset (yr)	47.18 ± 12.61	49.54 ± 10.13	0.131
Years of evolution	16.41 ± 9.72	15.45 ± 9.22	0.528
BMI (kg/mts2)	32.07 ± 5.26	31.45 ± 5.95	0.430
HbA1c (%)1	8.31 ± 1.87	8.16 ± 1.65	0.545
Total cholesterol (nmol/L)	5.07 ± 1.1	5.56± 1.5	0.010a
HDL (nmol/L)	1.23 ± 0.3	1.33 ± 0.3	0.010a
LDL (nmol/L)	2.86 ± 0.9	3.38 ± 1.7	0.009b
Triglycerides (nmol/L)	2.29 ± 1.4	2.81 ± 0.9	0.864
TG/HDL	2.10 ± 1.5	1.96 ± 2.0	0.572

¹At beginning of the study. Sample A vs Sample B:

^aP < 0.05,

^bP < 0.01 for all parameters. BMI: Body mass index; LDL: Low-density lipoprotein-cholesterol; HDL: High-density lipoprotein-cholesterol; TG/HDL: Insulin resistance index; HbA1c (%): Glycated hemoglobin percentage.